Literature DB >> 25283555

New antibacterial xanthone from the marine sponge-derived Micrococcus sp. EG45.

Enas E Eltamany1, Usama Ramadan Abdelmohsen2, Amany K Ibrahim1, Hashim A Hassanean1, Ute Hentschel2, Safwat A Ahmed3.   

Abstract

Microluside A [4 (19-para-hydroxy benzoyloxy-O-β-D-cellobiosyl), 5 (30-para-hydroxy benzoyloxy-O-β-D-glucopyranosyl) xanthone (1)] is a unique O-glycosylated disubstituted xanthone isolated from the broth culture of Micrococcus sp. EG45 cultivated from the Red Sea sponge Spheciospongia vagabunda. The structure of microluside A was determined by 1D- and 2D-NMR techniques as well as high resolution tandem mass spectrometry. The antimicrobial activity evaluation showed that 1 exhibited antibacterial potential against Enterococcus faecalis JH212 and Staphylococcus aureus NCTC 8325 with MIC values of 10 and 13 μM, respectively.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actinomycetes; Antimicrobial activity; Micrococcus sp.; Spheciospongia vagabunda; Xanthone

Mesh:

Substances:

Year:  2014        PMID: 25283555     DOI: 10.1016/j.bmcl.2014.09.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Sequencing rare marine actinomycete genomes reveals high density of unique natural product biosynthetic gene clusters.

Authors:  Michelle A Schorn; Mohammad M Alanjary; Kristen Aguinaldo; Anton Korobeynikov; Sheila Podell; Nastassia Patin; Tommie Lincecum; Paul R Jensen; Nadine Ziemert; Bradley S Moore
Journal:  Microbiology       Date:  2016-10-27       Impact factor: 2.777

2.  Inhibitory activities of the marine streptomycete-derived compound SF2446A2 against Chlamydia trachomatis and Schistosoma mansoni.

Authors:  Anastasija Reimer; Ariane Blohm; Thomas Quack; Christoph G Grevelding; Vera Kozjak-Pavlovic; Thomas Rudel; Ute Hentschel; Usama Ramadan Abdelmohsen
Journal:  J Antibiot (Tokyo)       Date:  2015-05-20       Impact factor: 2.649

Review 3.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

Review 4.  Bioprospecting Sponge-Associated Microbes for Antimicrobial Compounds.

Authors:  Anak Agung Gede Indraningrat; Hauke Smidt; Detmer Sipkema
Journal:  Mar Drugs       Date:  2016-05-02       Impact factor: 5.118

5.  Monitoring and assessment of the therapeutic impact of metabolites extracted from sponge-associated bacteria screened from Gulf of Mannar, southeast coast of India.

Authors:  Sinosh Skariyachan; Sneha Basavaraj Challapilli; Swathi Packirisamy; Vaishnavi Sneha Sridhar; Supreetha Toplar Kumargowda
Journal:  Environ Monit Assess       Date:  2020-03-18       Impact factor: 2.513

6.  Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges.

Authors:  Cheng Cheng; Lynsey MacIntyre; Usama Ramadan Abdelmohsen; Hannes Horn; Paraskevi N Polymenakou; RuAngelie Edrada-Ebel; Ute Hentschel
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

7.  Mining Genomes of Three Marine Sponge-Associated Actinobacterial Isolates for Secondary Metabolism.

Authors:  Hannes Horn; Ute Hentschel; Usama Ramadan Abdelmohsen
Journal:  Genome Announc       Date:  2015-10-01

8.  Diversity and antagonistic potential of marine microbes collected from south-west coast of India.

Authors:  S Sinimol; A R Sarika; A Jayakumaran Nair
Journal:  3 Biotech       Date:  2015-12-31       Impact factor: 2.406

Review 9.  Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials.

Authors:  Alka Choudhary; Lynn M Naughton; Itxaso Montánchez; Alan D W Dobson; Dilip K Rai
Journal:  Mar Drugs       Date:  2017-08-28       Impact factor: 5.118

10.  Isolation of Petrocidin A, a New Cytotoxic Cyclic Dipeptide from the Marine Sponge-Derived Bacterium Streptomyces sp. SBT348.

Authors:  Cheng Cheng; Eman M Othman; Helga Stopper; RuAngelie Edrada-Ebel; Ute Hentschel; Usama Ramadan Abdelmohsen
Journal:  Mar Drugs       Date:  2017-12-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.